EXEL SCHEDULE 13D/A: Activist campaign
Farallon Capital Management
Filed with the SEC on · accession 0000908834-26-000515
EXEL filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 9, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +3.1% by the first close after the filing.
Summary of the filing
Farallon Capital Management filed an amended Schedule 13D disclosing that it sold down its stake in Exelixis and ceased to be a beneficial owner of more than 5% of the company's shares as of November 6, 2026.
Key details
How EXEL stock reacted
Close before
$69.57
Nov 6, 2026
First close after
+3.12%
$71.74
5 trading days
—
Since filing
+1.45%
$70.58
✦ Ask GOAX AI about this filing — what it means for EXEL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EXEL?
Click hereFrequently asked questions
What did EXEL file with the SEC on Nov 9, 2026?
EXEL filed a SCHEDULE 13D/A (Activist campaign). Farallon Capital Management filed an amended Schedule 13D disclosing that it sold down its stake in Exelixis and ceased to be a beneficial owner of more than 5% of the company's shares as of November 6, 2026.
What does a activist campaign mean for EXEL stock?
A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did EXEL stock react to this filing?
EXEL closed at $69.57 before the filing and $71.74 on Nov 9, 2026 (+3.12%).
Other EXEL SEC filings
- SCHEDULE 13G · SEC filingNov 9, 2026
- 10-Q · SEC filingOct 29, 2026
- 8-K · SEC filingOct 29, 2026
- 8-K · Fda approvalSep 11, 2026
- 8-K · Regulatory actionAug 31, 2026
- SCHEDULE 13D/A · Activist campaignAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
- 144 · Insider sale plannedJun 1, 2026
Get alerts when EXEL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days